18+ · Research use only
CJC-1295 / Ipamorelin 5mg + 5mg, Philippines
Research blend; the blend itself has not been studied. Lyophilized powder, stocked in Metro Manila. For laboratory research use only.
Choose a pack
Pack price replaces the 10% off. One compound per pack.
Pack price replaces the standing 10% off; they don't stack. One compound per pack.
Check out once for the whole cart. Pay by QR, confirm on WhatsApp.
Add more compounds if you like, then check out once. You pay by QR on your order page and send the screenshot on WhatsApp.
In the Philippines
GCash · Maya · QR Ph bank transfer · InstaPay
From abroad
- International transfer
Wise · International bank transfer · Zelle · Crypto
Payment details are sent in the WhatsApp chat once your order is confirmed.
Order by 12 noon on a weekday for same-day Metro Manila
Includes water, syringes, pads · plain box
60-day money-back guaranteeTerms
Order by 12 noon on a weekday for same-day delivery in Metro Manila
Metro Manila rider ₱150 · Luzon 1-2 days · Visayas 2-3 days · Mindanao 3-5 days
Everything to reconstitute is included
5 x 3ml water · 50 syringes · 50 pads · plain outer packaging
60-day money-back guarantee
If an accredited independent laboratory reports that this vial is not the compound on the label, we refund what you paid for it. Evidence within 60 calendar days of delivery; you do not send anything back. Terms
Updated 12 October 2026
- Human evidence
- Phase 2
- Manufacturing
- cGMP · ISO 9001 · ISO 13485
- Latest batch report
- Report pending
- Storage
- 2 to 8 °C sealed
CJC-1295 / Ipamorelin in the Philippines
CJC-1295 and ipamorelin are growth hormone secretagogues studied together for complementary mechanisms: CJC-1295 extends GHRH signaling while ipamorelin provides a selective ghrelin-receptor pulse. The co-formulated blend is the standard configuration in secretagogue research.
Primara Labs stocks the blend as a co-lyophilized 5mg + 5mg vial at ₱2,650, or ₱2,390 with the standing 10% off. It is in stock with same-day Metro Manila dispatch on verified orders before noon.
This vial holds two peptides, 5mg + 5mg, freeze-dried together so there is only one vial to mix. Store it in the fridge before and after reconstitution. The order starts with the WhatsApp button, which writes the product into the chat for you; we reply with availability and the total, and Metro Manila orders confirmed before 12 noon get same-day Metro Manila delivery. How the ipamorelin half of the pair is studied is set out in the Ipamorelin guide.
Deeper read: CJC-1295 and Ipamorelin: the GH research pairing
Regulatory status
CJC-1295
Ipamorelin
CJC-1295. FDA Philippines: not established. US FDA: No record found. Checked 23 September 2026. Ipamorelin. FDA Philippines: not established. US FDA: No record found. Checked 23 September 2026.
Sold for laboratory research only, not for human consumption. Primara Labs does not give medical advice or dosing guidance. Regulatory Status Tracker
Laboratory handling
Reconstitution reference
| BAC water added | Resulting concentration | Note |
|---|---|---|
| 2.0 ml | 5 mg/ml combined | Common reference dilution |
Reconstitute with bacteriostatic water. Reference values are for laboratory preparation only. Other volumes: reconstitution calculator, prefilled for CJC-1295 / Ipamorelin 5mg + 5mg.
Handling and storage
Sealed vials
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light.
Primara Labs storage instructionAdding diluent
Add the diluent slowly down the inside wall of the vial rather than straight onto the powder.
Mixing
The US prescribing instructions for tesamorelin, a lyophilised peptide medicine, tell users to swirl the vial to mix the powder and liquid, and not to shake it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026Appearance
The same instructions say not to use the solution if it is cloudy, discoloured or has particles in it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026After the stopper is punctured
CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
CDC, Preventing Unsafe Injection Practices · checked 23 September 2026The CJC-1295 / Ipamorelin itself has not been studied. The findings below are for each component on its own.
Benefits studied: CJC-1295
Sustained growth hormone and IGF-1 rise
Small human studiesIn two small randomised, placebo-controlled trials in healthy adults aged 21 to 61, one injection of CJC-1295 (DAC form) raised mean growth hormone 2 to 10-fold for 6 days or more and IGF-1 1.5 to 3-fold for 9 to 11 days.
J Clin Endocrinol Metab 2006 · checked 23 September 2026Growth hormone pulses preserved
Small human studiesIn a non-randomised study of healthy men aged 20 to 40, one week after CJC-1295 trough growth hormone was 7.5-fold higher and IGF-1 45% higher, while the frequency and size of growth hormone pulses were unchanged.
J Clin Endocrinol Metab 2006 · checked 23 September 2026Growth in growth hormone-deficient mice
Animal and cellIn mice lacking growth hormone-releasing hormone, CJC-1295 treatment over 5 weeks produced normal body weight and length.
Am J Physiol Endocrinol Metab 2006 · checked 23 September 2026
Side effects reported: CJC-1295
The two healthy-volunteer trials report no serious adverse reactions; per-event rates are not given in the abstract.
J Clin Endocrinol Metab 2006 · checked 23 September 2026Benefits studied: Ipamorelin
Gut recovery after bowel surgery (not shown)
Phase 2 humanIn a phase 2 placebo-controlled trial of 117 patients after bowel resection, ipamorelin did not significantly shorten the time to a first tolerated solid meal (median 25.3 against 32.6 hours on placebo).
Int J Colorectal Dis 2014 · checked 23 September 2026Growth hormone release
Small human studiesIn a dose-escalation study in healthy men without a placebo arm, ipamorelin produced a single growth hormone peak at every dose studied.
Pharm Res 1999 · checked 23 September 2026Selective growth hormone release
Animal and cellIn pigs and rat pituitary cells, ipamorelin released growth hormone without raising ACTH or cortisol, unlike the comparison secretagogues.
Eur J Endocrinol 1998 · checked 23 September 2026
Side effects reported: Ipamorelin
In the phase 2 bowel-surgery trial, any treatment-emergent adverse event occurred in 87.5% on ipamorelin against 94.8% on placebo.
Int J Colorectal Dis 2014 · checked 23 September 2026Findings are described as the research reported them, with the level of evidence for each. They are not a claim about any vial sold here, which is supplied for laboratory research use only.
How it works
CJC-1295
CJC-1295 is a modified analogue of growth hormone-releasing hormone (GHRH 1-29). The form studied in people carries a reactive group that binds to albumin in the blood, which extends its half-life to several days and gives sustained rises in growth hormone and IGF-1.
Targets: GHRH receptor (pituitary)
Ipamorelin
Ipamorelin is a synthetic five-amino-acid growth hormone secretagogue that acts on the ghrelin receptor to release growth hormone from the pituitary. In animal pharmacology it released growth hormone without raising ACTH or cortisol, which is why its developers called it selective.
Targets: Ghrelin (GHS) receptor
What the research shows
CJC-1295
CJC-1295 is a long-acting analogue of growth hormone-releasing hormone. Its human evidence is two small randomised pharmacology trials in healthy adults, published in 2006, that measured growth hormone and IGF-1 rather than a clinical outcome. The human data are for the albumin-binding (DAC) form; no human trial of the form without DAC was found.
Animal and cell Human data are two small pharmacology trials of the DAC form; the rest is animal work.
- In growth hormone-deficient mice, CJC-1295 restored normal body weight and length. Am J Physiol Endocrinol Metab 2006 · checked 23 September 2026
- In rats, CJC-1295 gave a larger growth hormone response than GRF(1-29) and stayed in plasma beyond 72 hours. Endocrinology 2005 · checked 23 September 2026
Ipamorelin
Ipamorelin, a synthetic growth hormone secretagogue, has one completed phase 2 human trial, in patients recovering from bowel resection, and it found no significant difference from placebo. Other human data are pharmacology studies of growth hormone release in healthy men. Most of its literature is animal work.
Animal and cell One phase 2 human trial, which found no significant effect; the rest is animal work.
- In rat pituitary cells, rats and pigs, ipamorelin released growth hormone without ACTH or cortisol release. Eur J Endocrinol 1998 · checked 23 September 2026
- In adult female rats, ipamorelin increased longitudinal bone growth over 15 days. Growth Horm IGF Res 1999 · checked 23 September 2026
- In a rat model of post-surgical gut slowdown, ipamorelin improved faecal output, food intake and weight gain. J Pharmacol Exp Ther 2009 · checked 23 September 2026
The first published batch report is retatrutide 20mg batch RETA-4728-A, Janoshik-tested for bacterial endotoxin (key H2KI86I8GWB4), at primaralabs.com/coa. Reports for further compounds are published there per batch as they are issued.
CJC-1295
- Type
- Growth hormone-releasing hormone analogue
The name CJC-1295 resolves in PubChem to the albumin-binding (DAC) form, while the catalogue's formula matched the form without DAC. Identity fields are withheld until the supplier confirms which form the vial contains.
Ipamorelin
- Type
- Growth hormone secretagogue (pentapeptide)
- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.9 g/mol
- CAS
- 170851-70-4
- PubChem
- CID 9831659
- Sequence
- Aib-His-D-2Nal-D-Phe-Lys-NH2
- Presentation
- Co-lyophilized powder, 5 mg + 5 mg / vial
- Vial size
- 5mg + 5mg
- Catalogue code
- PRM-007
Frequently asked
CJC-1295 / Ipamorelin questions, answered
How much is CJC-1295 / Ipamorelin in the Philippines?
At Primara Labs, CJC-1295 / Ipamorelin 5mg + 5mg is ₱2,390 for a single vial, ₱1,855 per vial in a 5 pack (₱9,275 total) and ₱1,458 per vial in a 10 pack (₱14,580 total). Prices are in pesos and the pack price is shown on the product page before you order.
Where can I buy CJC-1295 / Ipamorelin in the Philippines?
Primara Labs keeps CJC-1295 / Ipamorelin 5mg + 5mg in stock in Metro Manila cold storage. Order on WhatsApp from the product page: the message is typed for you, and stock, the total and delivery are confirmed in the chat. There is no on-site checkout.
Do you deliver CJC-1295 / Ipamorelin to Cebu, Davao and the provinces?
Yes. Metro Manila: same day before 12 noon, Grab Express / Lalamove, ₱150; Luzon: 1 to 2 business days, J&T Express, ₱250; Visayas: 2 to 3 business days, J&T Express, ₱250; Mindanao: 3 to 5 business days, J&T Express, ₱300. Cebu is in the Visayas and Davao in Mindanao. Courier is free on orders over ₱10,000 anywhere in the Philippines. Below that, a Metro Manila rider is ₱150, J&T Express is ₱250 to Luzon and the Visayas and ₱300 to Mindanao.
Is CJC-1295 / Ipamorelin FDA approved in the Philippines?
CJC-1295. FDA Philippines: not established. US FDA: No record found. Checked 23 September 2026. Ipamorelin. FDA Philippines: not established. US FDA: No record found. Checked 23 September 2026. Primara Labs supplies it for research use only; it is not for human consumption.
Is the blend currently available?
It is in stock. Verified orders placed before noon dispatch the same day across Metro Manila, with courier delivery reaching Luzon in 1 to 2 business days, the Visayas in 2 to 3 and Mindanao in 3 to 5.
Why are the two peptides co-formulated?
They act on different receptors in the GH axis, so secretagogue research protocols run them together. Co-lyophilization keeps the 1:1 ratio consistent per vial.
Has the CJC-1295 / Ipamorelin itself been studied?
No. The CJC-1295 / Ipamorelin combines CJC-1295, Ipamorelin in one vial, and the blend itself has not been studied. Each component's evidence is set out separately: CJC-1295, small human studies; Ipamorelin, phase 2 human.
What is CJC-1295 studied for?
CJC-1295 is a long-acting analogue of growth hormone-releasing hormone. Its human evidence is two small randomised pharmacology trials in healthy adults, published in 2006, that measured growth hormone and IGF-1 rather than a clinical outcome. The human data are for the albumin-binding (DAC) form; no human trial of the form without DAC was found.
What is Ipamorelin studied for?
Ipamorelin, a synthetic growth hormone secretagogue, has one completed phase 2 human trial, in patients recovering from bowel resection, and it found no significant difference from placebo. Other human data are pharmacology studies of growth hormone release in healthy men. Most of its literature is animal work.
What side effects were reported for the CJC-1295 / Ipamorelin components?
CJC-1295: The two healthy-volunteer trials report no serious adverse reactions; per-event rates are not given in the abstract. Ipamorelin: In the phase 2 bowel-surgery trial, any treatment-emergent adverse event occurred in 87.5% on ipamorelin against 94.8% on placebo.
How should CJC-1295 / Ipamorelin be stored?
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light. CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
Does Primara Labs publish lab reports for CJC-1295 / Ipamorelin?
The first published batch report is retatrutide 20mg batch RETA-4728-A, Janoshik-tested for bacterial endotoxin (key H2KI86I8GWB4), at primaralabs.com/coa. Reports for further compounds are published there per batch as they are issued.
Related compounds
Answers
Questions about CJC-1295 / Ipamorelin, answered
All compounds supplied by Primara Labs are for laboratory research use only and are not for human consumption, diagnostic or therapeutic use. Statements on this page describe published research and have not been evaluated by the Philippine FDA. See Research Use Only terms.